project id: TCGA-PRAD; case submitter id: TCGA-CH-5792; selected normal wgs: true; state: released; spectrophotometer method: UV Spec; age at index: 57; days to birth: -21002; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 21002; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic t: T3a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 91.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 28.0; intermediate dimension: 0.5; longest dimension: 1.4; preservation method: Unknown; shortest dimension: 0.4; sample id: da5f8107-7b69-45b5-8beb-21d17b066cb4; sample submitter id: TCGA-CH-5792-01A; portion id: bc7f9b85-e644-4bd1-bc49-5a5cfdfe67cb; portion submitter id: TCGA-CH-5792-01A-11; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 25.0; percent tumor cells: 55.0; percent tumor nuclei: 60.0;